Hybrid Friday Lecture Series
(open to the Rockefeller and Tri-Institutional communities)
Friday, October 18, 2024
Carolyn Bertozzi, Ph.D.
Baker Family Director of Sarafan Stanford ChEM-H and the Anne T. and Robert M. Bass Professor of Humanities and Sciences in the Department of Chemistry, Stanford University; Investigator, Howard Hughes Medical Institute
Cancer Immune Therapies from Glycoscience
Student Sponsored / The Bruce Merrifield Distinguished Lecture
Recommended Readings:
Liu, Jingyi, et al. “Glycosylation and Its Role in Immune Checkpoint Proteins: From Molecular Mechanisms to Clinical Implications.” Biomedicines 12.7 (2024): 1446.
Ren, Xueting, et al. “Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy.” International Journal of Biological Sciences 20.7 (2024): 2607.
Berois, Nora, Alvaro Pittini, and Eduardo Osinaga. “Targeting tumor glycans for cancer therapy: successes, limitations, and perspectives.” Cancers 14.3 (2022): 645.
Daly, John, Mattias Carlsten, and Michael O’Dwyer. “Sugar free: novel immunotherapeutic approaches targeting siglecs and sialic acids to enhance natural killer cell cytotoxicity against cancer.” Frontiers in immunology 10 (2019): 1047.
Xiao, Han, et al. “Precision glycocalyx editing as a strategy for cancer immunotherapy.” Proceedings of the National Academy of Sciences 113.37 (2016): 10304-10309.
